News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
90,545 Results
Type
Article (6639)
Company Profile (41)
Press Release (83865)
Section
Business (27686)
Career Advice (125)
Deals (3985)
Drug Delivery (30)
Drug Development (14088)
Employer Resources (12)
FDA (2826)
Job Trends (2107)
News (49115)
Policy (5988)
Tag
Academia (422)
Allergies (21)
Alliances (8924)
Alzheimer's disease (234)
Antibody-drug conjugate (ADC) (24)
Approvals (2809)
Artificial intelligence (21)
Bankruptcy (18)
Best Places to Work (1778)
BIOSECURE Act (15)
Biosimilars (52)
Biotechnology (29)
Breast cancer (22)
Cancer (222)
Career advice (108)
Cell therapy (47)
Clinical research (11145)
Collaboration (85)
Compensation (17)
COVID-19 (530)
C-suite (23)
Data (222)
Diabetes (20)
Diagnostics (508)
Drug pricing (15)
Earnings (9208)
Events (11466)
Executive appointments (40)
FDA (2974)
Funding (61)
Gene therapy (51)
GLP-1 (96)
Government (1287)
Healthcare (1939)
Immunology and inflammation (19)
Infectious disease (547)
Inflammatory bowel disease (40)
IPO (1820)
Job creations (385)
Job search strategy (106)
Layoffs (48)
Legal (553)
Lung cancer (52)
Manufacturing (68)
Medical device (1155)
Medtech (1156)
Mergers & acquisitions (2208)
Metabolic disorders (45)
Neuroscience (275)
NextGen Class of 2024 (697)
Non-profit (345)
Northern California (272)
Obesity (16)
Opinion (39)
Patents (13)
Peanut (18)
People (7812)
Phase I (3659)
Phase II (4648)
Phase III (4077)
Pipeline (131)
Policy (27)
Postmarket research (293)
Preclinical (1434)
Press Release (66)
Radiopharmaceuticals (34)
Rare diseases (33)
Real estate (911)
Regulatory (4552)
Research institute (387)
Southern California (286)
Startups (572)
United States (2427)
Vaccines (140)
Date
Today (50)
Last 7 days (197)
Last 30 days (685)
Last 365 days (6564)
2024 (5934)
2023 (6963)
2022 (9060)
2021 (9473)
2020 (8175)
2019 (5843)
2018 (4511)
2017 (5056)
2016 (4617)
2015 (5268)
2014 (3717)
2013 (2892)
2012 (2984)
2011 (3146)
2010 (2572)
Location
Africa (91)
Asia (7315)
Australia (865)
California (630)
Canada (155)
China (91)
Colorado (23)
Delaware (16)
Europe (13548)
Florida (69)
Idaho (13)
Illinois (30)
Indiana (25)
Maryland (228)
Massachusetts (425)
Minnesota (36)
New Jersey (272)
New York (175)
North Carolina (147)
Northern California (272)
Ohio (27)
Pennsylvania (115)
South America (134)
Southern California (286)
Texas (70)
Washington State (53)
90,545 Results for "cytovance biologics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
ExcellGene SA and Cytovance Biologics Join Forces to Transform Large Molecule Biologics Development and Manufacture
ExcellGene SA proudly announces its strategic collaboration with Cytovance Biologics, a renowned Contract Development and Manufacturing Organization based in the USA.
May 8, 2024
·
3 min read
Cytovance Biologics and Alcami Unite to Deliver End-to-End Solutions for Biologics Developers
Cytovance Biologics has announced a strategic collaboration with fellow CDMO Alcami Corporation to expand its large molecule biologic manufacturing and sterile fill finish offering.
December 11, 2023
·
3 min read
Cytovance Biologics Announces Dr. Axel Schleyer to Expand Footprint and Service Offering as Chief Commercial Officer
Cytovance Biologics, a leading full-service mammalian and microbial large molecule contract development and manufacturing organization (CDMO), announced today the addition of Axel Schleyer, Ph.D., MBA,
September 26, 2023
·
2 min read
Large Molecule CDMO, Cytovance Biologics, and Custom Strain Development Expert, Vectron Biosolutions, Partner to Improve Development of Complex Microbial Molecules
Cytovance Biologics announced a strategic, international collaboration with Vectron Biosolutions to add customized E. coli strain development to the CDMO’s microbial program.
October 10, 2023
·
5 min read
Business
Cytovance Biologics Announces Ping Zhang as Chief Executive Officer
Cytovance® Biologics announces the appointment of Mr. Ping Zhang as Chief Executive Officer.
January 16, 2023
·
2 min read
Business
Cytovance Biologics and Phenotypeca Collaborate to Enhance Saccharomyces cerevisiae Strain Development for Microbial Biomanufacturing
Cytovance Biologics, Inc. and Phenotypeca Limited have entered into an agreement to provide optimized Saccharomyces cerevisiae strains for biopharmaceutical manufacturing.
March 11, 2023
·
3 min read
Business
Cytovation Announces Appointment of Ellen Lubman, MBA to its Board of Directors
Cytovation ASA, a clinical stage immune-oncology company focused on the development of its first-in-class targeted tumour membrane immunotherapy CyPep-1, announced the election of Ellen Lubman, MBA, to its Board of Directors.
December 20, 2023
·
3 min read
Press Releases
Cytovation to present full safety and efficacy data from the CICILIA Phase I/IIa trial evaluating CY-101 in solid tumors at ESMO 2024
September 13, 2024
·
3 min read
News
Webinar: Revolutionizing Biologics Discovery: Harnessing the Power of AI and Patent Data
This webinar explores the pivotal role of patent data in overcoming the data challenges faced by generative AI models in drug discovery, particularly for biologics. Watch now.
October 23, 2024
·
1 min read
·
BioSpace Insights
Approvals
AstraZeneca Wins Rare Autoimmune Indication for Asthma Biologic Fasenra
With the FDA’s approval, Fasenra will compete with GSK’s Nucala, which in December 2017 became the first biologic approved for eosinophilic granulomatosis with polyangiitis.
September 19, 2024
·
2 min read
·
Tristan Manalac
1 of 9,055
Next
